60 related articles for article (PubMed ID: 12740642)
1. Expression of p65, DD3 and c-erbB2 genes in prostate cancer.
Balcerczak E; Mirowski M; Sasor A; Wierzbicki R
Neoplasma; 2003; 50(2):97-101. PubMed ID: 12740642
[TBL] [Abstract][Full Text] [Related]
2. p65 and c-erbB2 genes expression in breast tumors: comparison with some histological typing, grading and clinical staging.
Balcerczak E; Mirowski M; Jesionek-Kupnicka D; Bartkowiak J; Kubiak R; Wierzbicki R
J Exp Clin Cancer Res; 2003 Jun; 22(2):247-53. PubMed ID: 12866575
[TBL] [Abstract][Full Text] [Related]
3. Is DD3 a new prostate-specific gene?
Gandini O; Luci L; Stigliano A; Lucera R; Di Silverio F; Toscano V; Cardillo MR
Anticancer Res; 2003; 23(1A):305-8. PubMed ID: 12680228
[TBL] [Abstract][Full Text] [Related]
4. Expression of human telomerase reverse transcriptase, Survivin, DD3 and PCGEM1 messenger RNA in archival prostate carcinoma tissue.
Bialkowska-Hobrzanska H; Driman DK; Fletcher R; Harry V; Razvi H
Can J Urol; 2006 Feb; 13(1):2967-74. PubMed ID: 16515751
[TBL] [Abstract][Full Text] [Related]
5. The combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancer.
Mearini E; Antognelli C; Del Buono C; Cochetti G; Giannantoni A; Nardelli E; Talesa VN
Biomarkers; 2009 Jun; 14(4):235-43. PubMed ID: 19489685
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction].
Tao ZH; Mao XL; Wang CH; Chen XD; Yu KY; Weng ZL; Hu YP; Zhang XH; Xie H; Wang OC; Song QT; Li CD; Chen ZG
Zhonghua Nan Ke Xue; 2007 Feb; 13(2):130-3. PubMed ID: 17345768
[TBL] [Abstract][Full Text] [Related]
7. Expression of the p65 gene in patients with colorectal cancer: comparison with some histological typing, grading and clinical staging.
Balcerczak M; Balcerczak E; Pasz-Walczak G; Kordek R; Mirowski M
Eur J Surg Oncol; 2004 Apr; 30(3):266-70. PubMed ID: 15028307
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of polyclonal antibodies raised against P65 oncofetal protein in immunohistochemical diagnosis of ductal breast cancer.
Niewiadomska H; Mirowski M; Switalska J; Balcerczak E; Kubiak R; Wierzbicki R
J Exp Clin Cancer Res; 2004 Mar; 23(1):113-9. PubMed ID: 15149159
[TBL] [Abstract][Full Text] [Related]
9. cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers.
Cantile M; Kisslinger A; Cindolo L; Schiavo G; D'Antò V; Franco R; Altieri V; Gallo A; Villacci A; Tramontano D; Cillo C
J Cell Physiol; 2005 Nov; 205(2):202-10. PubMed ID: 15895411
[TBL] [Abstract][Full Text] [Related]
10. [Detection of DD3 mRNA in the urine of prostate cancer patients and its clinical significance].
Liu GX; Guo HQ; Li XG; Gan WD; Zeng LQ; Shi HL; Zhang SW; Liu TS
Zhonghua Nan Ke Xue; 2007 Jun; 13(6):511-3. PubMed ID: 17615974
[TBL] [Abstract][Full Text] [Related]
11. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative detection of differential display code 3 mRNA in peripheral blood of patients with prostate cancer].
Weng ZL; Yu KY; Mao XL; Tao ZH; Chen XD; Wu XL; Hu YP; Wang SQ; Li CD; Chen ZG
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2911-5. PubMed ID: 17288789
[TBL] [Abstract][Full Text] [Related]
13. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
[TBL] [Abstract][Full Text] [Related]
16. Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events.
Sirotnak FM; She Y; Khokhar NZ; Hayes P; Gerald W; Scher HI
Mol Carcinog; 2004 Nov; 41(3):150-63. PubMed ID: 15390081
[TBL] [Abstract][Full Text] [Related]
17. Cellular expression, localization and interactions of the product of the human MOST-1 gene associated with breast and prostate cancers.
Tan JM; Chow VT
Int J Oncol; 2007 Jan; 30(1):81-9. PubMed ID: 17143515
[TBL] [Abstract][Full Text] [Related]
18. [Detection of urine DD3/PSA mRNA ratio by duplex TaqMan RT-PCR assay and evolution of its primary application].
Chen FP; Chen LL; Shen M; Chen W; Tao ZH; Wu XL; Hu YP; Li CD; Chen ZG; Chen XD
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):261-4. PubMed ID: 18361839
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
[TBL] [Abstract][Full Text] [Related]
20. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
